Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis

被引:239
作者
Lievens, Dirk [1 ,2 ]
Zernecke, Alma [2 ]
Seijkens, Tom [1 ]
Soehnlein, Oliver [2 ]
Beckers, Linda [1 ]
Munnix, Imke C. A. [3 ]
Wijnands, Erwin [1 ]
Goossens, Pieter [4 ]
van Kruchten, Roger [3 ]
Thevissen, Larissa [2 ]
Boon, Louis [5 ]
Flavell, Richard A. [6 ,7 ]
Noelle, Randolph J. [8 ,9 ,10 ]
Gerdes, Norbert [2 ]
Biessen, Erik A. [1 ]
Daemen, Mat J. A. P. [1 ]
Heemskerk, JohanW. M. [3 ]
Weber, Christian [1 ,2 ]
Lutgens, Esther [1 ,2 ]
机构
[1] Univ Maastricht, Dept Pathol, Cardiovasc Res Inst Maastricht, Maastricht Ctr Atherosclerosis Res, NL-6229 HX Maastricht, Netherlands
[2] Rhein Westfal Tech Hsch Aachen Univ, Inst Mol Cardiovasc Res, Aachen, Germany
[3] Univ Maastricht, Dept Biochem, Cardiovasc Res Inst Maastricht, Maastricht Ctr Atherosclerosis Res, NL-6229 HX Maastricht, Netherlands
[4] Univ Maastricht, Dept Mol Genet, Cardiovasc Res Inst Maastricht, Maastricht Ctr Atherosclerosis Res, NL-6229 HX Maastricht, Netherlands
[5] Bioceros BV, Utrecht, Netherlands
[6] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA
[7] Yale Univ, Howard Hughes Med Inst, Sch Med, New Haven, CT 06511 USA
[8] Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH USA
[9] Norris Cotton Canc Ctr, Lebanon, NH USA
[10] Kings Coll London, MRC, Ctr Transplantat, London WC2R 2LS, England
关键词
RECEPTOR-DEFICIENT MICE; ENDOTHELIAL-CELLS; APOLIPOPROTEIN-E; LESION FORMATION; FUNCTIONAL INTERACTIONS; CARDIOVASCULAR-DISEASE; NEOINTIMA FORMATION; MONOCYTE COMPLEXES; GLYCOPROTEIN-VI; TISSUE FACTOR;
D O I
10.1182/blood-2010-01-261206
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CD40 ligand (CD40L), identified as a costimulatory molecule expressed on T cells, is also expressed and functional on platelets. We investigated the thrombotic and inflammatory contributions of platelet CD40L in atherosclerosis. Although CD40L-deficient (Cd40l(-/-))platelets exhibited impaired platelet aggregation and thrombus stability, the effects of platelet CD40L on inflammatory processes in atherosclerosis were more remarkable. Repeated injections of activated Cd40l(-/-) platelets into Apoe(-/-) mice strongly de-creased both platelet and leukocyte adhesion to the endothelium and decreased plasma CCL2 levels compared with wildtype platelets. Moreover, Cd40l(-/-) platelets failed to form proinflammatory platelet-leukocyte aggregates. Expression of CD40L on platelets was required for plateletinduced atherosclerosis as injection of Cd40l(-/-) platelets in contrast to Cd40l(-/-) platelets did not promote lesion formation. Remarkably, injection of Cd40l(-/-), but not Cd40l(-/-), platelets transiently decreased the amount of regulatory T cells (Tregs) in blood and spleen. Depletion of Tregs in mice injected with activated Cd40l(-/-) platelets abrogated the athero-protective effect, indicating that CD40L on platelets mediates the reduction of Tregs leading to accelerated atherosclerosis. We conclude that platelet CD40L plays a pivotal role in atherosclerosis, not only by affecting platelet-platelet interactions but especially by activating leukocytes, thereby increasing platelet-leukocyte and leukocyte-endothelium interactions. (Blood. 2010;116(20):4317-4327)
引用
收藏
页码:4317 / 4327
页数:11
相关论文
共 56 条
[1]   Natural regulatory T cells control the development of atherosclerosis in mice [J].
Ait-Oufella, H ;
Salomon, BL ;
Potteaux, S ;
Robertson, AKL ;
Gourdy, P ;
Zoll, J ;
Merval, R ;
Esposito, B ;
Cohen, JL ;
Fisson, S ;
Flavell, RA ;
Hansson, GK ;
Klatzmann, D ;
Tedgui, A ;
Mallat, Z .
NATURE MEDICINE, 2006, 12 (02) :178-180
[2]   Platelet-derived CD40L -: The switch-hitting player of cardiovascular disease [J].
André, P ;
Nannizzi-Alaimo, L ;
Prasad, SK ;
Phillips, DR .
CIRCULATION, 2002, 106 (08) :896-899
[3]   CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism [J].
André, P ;
Prasad, KSS ;
Denis, CV ;
He, M ;
Papalia, JM ;
Hynes, RO ;
Phillips, DR ;
Wagner, DD .
NATURE MEDICINE, 2002, 8 (03) :247-252
[4]   MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment [J].
Bernhagen, Juergen ;
Krohn, Regina ;
Lue, Hongqi ;
Gregory, Julia L. ;
Zernecke, Alma ;
Koenen, Rory R. ;
Dewor, Manfred ;
Georgiev, Ivan ;
Schober, Andreas ;
Leng, Lin ;
Kooistra, Teake ;
Fingerle-Rowson, Guenter ;
Ghezzi, Pietro ;
Kleemann, Robert ;
McColl, Shaun R. ;
Bucala, Richard ;
Hickey, Michael J. ;
Weber, Christian .
NATURE MEDICINE, 2007, 13 (05) :587-596
[5]   Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis [J].
Boring, L ;
Gosling, J ;
Cleary, M ;
Charo, IF .
NATURE, 1998, 394 (6696) :894-897
[6]   CD40 ligand influences platelet release of reactive oxygen intermediates [J].
Chakrabarti, S ;
Varghese, S ;
Vitseva, O ;
Tanriverdi, K ;
Freedman, JE .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (11) :2428-2434
[7]   CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation [J].
Crittenden, JR ;
Bergmeier, W ;
Zhang, YY ;
Piffath, CL ;
Liang, YQ ;
Wagner, DD ;
Housman, DE ;
Graybiel, AM .
NATURE MEDICINE, 2004, 10 (09) :982-986
[8]   The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling [J].
Donners, Marjo M. P. C. ;
Beckers, Linda ;
Lievens, Dirk ;
Munnix, Imke ;
Heemskerk, Johan ;
Janssen, Ben J. ;
Wijnands, Erwin ;
Cleutjens, Jack ;
Zernecke, Alma ;
Weber, Christian ;
Ahonen, Cory L. ;
Benbow, Ulrike ;
Newby, Andrew C. ;
Noelle, Randolph J. ;
Daemen, Mat J. A. P. ;
Lutgens, Esther .
BLOOD, 2008, 111 (09) :4596-4604
[9]  
ELVERS M, SCI SIGNAL, V3, pRA1
[10]   PLATELET ACTIVATION IN UNSTABLE CORONARY-DISEASE [J].
FITZGERALD, DJ ;
ROY, L ;
CATELLA, F ;
FITZGERALD, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (16) :983-989